Mobile Menu - OpenMobile Menu - Closed

Congressman Andy Harris

Representing the First District of Maryland

Rep. Harris Issues Statement on Right to Try Act

May 22, 2018
Press Release

WASHINGTON, DC: On May 22, the U.S. House of Representatives passed S. 204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act. This legislation increases terminally ill patients’ access to experimental drugs that have not yet been approved or licensed by the FDA. Congressman Andy Harris, M.D. (MD-01) issued the following statement lauding the bill’s passage:

“Today, the House of Representatives delivered new hope to patients fighting for their lives. Stunning new cures in medicine occur each and every day, and patients deserve the right to try any and all available treatments, including treatment options still in the final approval process. The federal government has no place denying terminally-ill patients the opportunity for survival, especially when there are hundreds of potential treatments stuck in the FDA’s pipeline. As a physician, I am proud to support the Right to Try Act – a bill that will bring hope and relief to families plagued by terminal illness across the United States.”

###

Issues: